PerkinElmer, Inc. (PKI) Director Sells $365,900.00 in Stock

PerkinElmer, Inc. (NYSE:PKI) Director Alexis P. Michas sold 5,000 shares of the company’s stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $73.18, for a total transaction of $365,900.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

PerkinElmer, Inc. (NYSE PKI) opened at $73.12 on Monday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.09 and a current ratio of 2.59. The firm has a market cap of $8,059.67, a PE ratio of 26.30, a price-to-earnings-growth ratio of 2.19 and a beta of 0.77. PerkinElmer, Inc. has a 12 month low of $50.51 and a 12 month high of $74.11.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Stockholders of record on Friday, January 19th will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Thursday, January 18th. This represents a $0.28 annualized dividend and a dividend yield of 0.38%. PerkinElmer’s dividend payout ratio is presently 7.78%.

PKI has been the subject of a number of analyst reports. Robert W. Baird upped their price objective on shares of PerkinElmer from $75.00 to $78.00 and gave the company an “outperform” rating in a report on Friday, November 3rd. Morgan Stanley upped their price objective on shares of PerkinElmer from $77.00 to $78.00 and gave the company an “overweight” rating in a report on Friday, November 3rd. Jefferies Group reissued a “hold” rating and issued a $70.00 price objective on shares of PerkinElmer in a report on Friday, October 20th. Goldman Sachs Group reissued a “neutral” rating and issued a $67.00 price objective on shares of PerkinElmer in a report on Tuesday, September 26th. Finally, Cowen reissued a “hold” rating and issued a $70.00 price objective on shares of PerkinElmer in a report on Friday, September 1st. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and six have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $68.64.

Several institutional investors and hedge funds have recently modified their holdings of PKI. Acrospire Investment Management LLC lifted its position in shares of PerkinElmer by 185.7% during the second quarter. Acrospire Investment Management LLC now owns 2,000 shares of the medical research company’s stock worth $136,000 after purchasing an additional 1,300 shares in the last quarter. LS Investment Advisors LLC lifted its position in shares of PerkinElmer by 2.1% during the second quarter. LS Investment Advisors LLC now owns 2,877 shares of the medical research company’s stock worth $196,000 after purchasing an additional 60 shares in the last quarter. Waldron LP acquired a new stake in shares of PerkinElmer during the third quarter worth about $200,000. Seaward Management Limited Partnership acquired a new stake in shares of PerkinElmer during the third quarter worth about $202,000. Finally, Carret Asset Management LLC acquired a new stake in shares of PerkinElmer during the second quarter worth about $210,000. 91.66% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: This article was first posted by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another site, it was illegally copied and reposted in violation of United States and international copyright legislation. The legal version of this article can be read at https://www.com-unik.info/2017/12/04/perkinelmer-inc-pki-director-sells-365900-00-in-stock.html.

PerkinElmer Company Profile

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Insider Buying and Selling by Quarter for PerkinElmer (NYSE:PKI)

What are top analysts saying about PerkinElmer Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for PerkinElmer Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit